Azizov & Partners
Baker McKenzie LLP
Curtis, Mallet-Prevost, Colt & Mosle LLP
Dentons
GRATA International
Kinstellar
KPMG in Azerbaijan
Morgan, Lewis & Bockius LLP
Olympex Advisers LLP
Synergy Partners Law Firm LLC
Taher Group Law Firm (TAG)
TKS Disputes
Unicase Law Firm
Vakhidov & Partners
Verum LLP
White & Case LLP
Comparative Guides
View
Kazakhstan: Pharmaceutical Advertising
Contribution fromGRATA International
Kazakhstan: Doing Business In
Contribution fromUnicase Law Firm
News & Developments
View
Taxation of Dividends in Kazakhstan: Challenges and Practical Aspects for International Investors
Kazakhstan retains its key investment advantages, such as its geographical location, market access, vast natural resources, and human capital.
Olympex Advisers LLP - 26 July 2024
Amendments to the Rules for Labelling and Traceability of Medicines have been introduced
The main change concerns the list of goods subject to digital labelling, which was approved by the Resolution of the Government of the Republic of Kazakhstan (“Kazakhstan”) dated June 28, 2024, No. 516 (“Resolution”).
Vakhidov & Partners - 30 September 2024
Amendments have been introduced into the Code of the Republic of Kazakhstan dated July 7, 2020 No. 360-VI “On the Health of the People and the Healthcare system”
The Law of the Republic of Kazakhstan (hereinafter – the “RK”) dated April 6,
Vakhidov & Partners - 24 June 2024
The Law of the Republic of Kazakhstan “On Amendments and Additions to Certain Legislative Acts of the Republic of Kazakhstan on Health Issues” was signed
The President of the Republic of Kazakhstan (“RK”) signed the Law of the RK dated April 19,
Vakhidov & Partners - 24 June 2024